By Logan Kastner, MRA Director of Marketing and Development | 24 November 2015 In Allies & Partnerships
Partnering for Cures: How Patients Can Stop Talking and Start Doing Something
Earlier this week, more than 700 thought leaders from throughout the healthcare industry gathered in New York for FasterCures’ Partnering for Cures meeting. This annual event brings together a variety of decision-makers from across diseases who are motivated by the same mission – to reduce the time and cost of...
Immunotherapy Patient Forum: 6 Reasons to Attend
27 October 2015 In Events
On November 7, the Melanoma Research Alliance is co-hosting a Patient Forum on Immunology with Global Resource for Advancing Cancer Education and the Society for Immunotherapy of Cancer. The event will be held at the National Harbor, near Washington, DC. Online registration is open through October 30.
A Father Shares His Family's Journey with Melanoma
In this guest blog post, Skip Grinberg shares his family's experience with melanoma and his drive to advance research. [caption id="attachment_1505" align="alignright" width="300"] Skip Grinberg and his extended family[/caption] Life can occasionally throw you a sharp-breaking curveball.
Melanoma and the Problem of Drug Resistance
8 October 2015 In Science
In 2002, researchers discovered a link between mutated BRAF genes and nearly half of all melanoma tumors. Since then, BRAF inhibitors—drugs that target mutated BRAF—have become a leading go-to weapon in the battle against melanoma. Their job is to cut off signals sent by altered BRAF that promote the rapid...
Researcher Q&A: Dr. Niroshana Anandasabapathy
30 September 2015 In Science
In our latest research feature, we spoke with Niroshana Anandasabapathy of Brigham and Women’s Hospital, who is the recipient of an MRA Young Investigator Award. Funded in collaboration with Brigham and Women’s Hospital, Dr. Anandasabapathy’s research is titled “Expanding immune-surveillance and immunotherapy of melanoma.” Here she explains more about her research.
The Latest on Skin Cancer Screenings
22 September 2015 In Science
To routinely screen for skin cancer or not to screen? That hot-button question still doesn’t have a solid answer. In 2009, the U.S. Preventive Services Task Force found insufficient evidence to recommend annual skin cancer screenings for all adults.
MRA Announces RFP for Translational Research
16 September 2015 In Science
MRA is pleased to announce a Request for Proposals (RFP) soliciting high-impact translational research from scientists and clinicians around the world. This RFP is for 2015-2016, with awards being announced in the spring of 2016. The RFP calls for ideas that have the potential to lead to near-term clinical application...
Researcher Q&A: Dr. Neil Ganem
2 September 2015 In Science
In an effort to share more about the work being done in the field of melanoma research, we are beginning a new feature on our blog to showcase some of our funded investigators. Today we’re talking with Neil Ganem, Ph.D., Assistant Professor of Pharmacology and Medicine at Boston University School of...
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People